La gestion de l’Avastin par le bioéthicien : transfert d’une responsabilité politique?

Avastin is a paradigmatic example of a common situation in the health system: the introduction of promising but very expensive new drugs. This situation disrupts the delicate balance of the health system and causes problems for various stakeholders such as patients, health professionals, bioethicists and managers.